The investment in Fairshot amounts to £12,500.00 (approximately €14,330.00) and is part of a broader £800,000.00 fundraising round structured through the issuance of a SAFE (Simple Agreement for Future Equity), with a valuation cap set at £4 million. The proceeds from this round will be deployed over the next 12 to 18 months to support product development and to launch a pilot programme in partnership with an investment firm and two major consulting companies. From a structural perspective, the investment is executed through the subscription of a SAFE issued by the target company. Individual investors gain exposure indirectly by participating via the Avvio Capital Investment Circle, which aggregates capital and facilitates access to the opportunity.

The investment in Mixum amounts to €855,750.00 and is part of its latest funding round, structured through a capital increase in Mixtio S.r.l. Of this amount, €855.79 is allocated to share capital, while the remaining €854,894.21 is recorded as share premium, implying a valuation of €11.36 million. The proceeds from this round are intended to support the company’s operational scale-up, specifically financing the development of its production facility, covering wages and salaries, and supporting ongoing working capital needs. From a structural standpoint, the investment is executed through the subscription of newly issued shares in the target company. Individual investors access the opportunity indirectly by participating through the Avvio Capital Investment Circle, which aggregates capital and facilitates entry into the deal.

As part of a $500 million Series D funding round at a valuation of $6.8 billion, Exep subscribed for shares worth USD 799,834.00. The investment in Cohere is being made through the subscription of newly issued preference shares at a price of USD 230.7125 per share by the special purpose vehicle Inovia Coinversors SPV IV Limited Partnership, in which EXEP in turn holds a stake through the vehicle EXEP SPV I S.r.l.

The investment in Gotobeat amounts to €55,000.00 and is part of a broader funding round totaling £1.5 million. This capital increase, approved on October 15, 2025, consists of a nominal share capital component of £15.71 and a share premium of approximately £1.5 million, implying a pre-money valuation of £10.5 million and a price per share of £95.45. The proceeds from this round are intended to support the company’s next phase of growth, specifically by strengthening the core team, further developing the platform, and initiating expansion into additional European markets. From a structural perspective, the investment is executed through the subscription of newly issued preferred shares in the target company. Individual investors gain exposure to this opportunity indirectly, by participating through the Avvio Capital Investment Circle, which aggregates capital and facilitates access to the deal.